Video/ Infection Control

'Superbug' fungus emerging in N.Y. region

Two of the three kinds of commonly used antifungal drugs have little effect


The "superbug" fungus, Candida auris, is emerging as a new menace in U.S. hospitals, mostly in New York and New Jersey, according to an article and video on the AP website.
 
Two of the three kinds of commonly used antifungal drugs have little effect on C. auris
 
Infections related to the fungas tend to be diagnosed in patients after they've been in hospitals for several weeks. The fungus can infect wounds, ears and the bloodstream.
 
A recent study found the fungus on surfaces in hospital rooms and on the skin of nurses and patients — even after patients were treated with antifungal medications.
 
 



May 5, 2017


Topic Area: Infection Control


Recent Posts

Cyberattack Results in Patient Reroutes at Anne Arundel Medical Center

A recent cyberattack on Luminis Health Care led to care disruptions and treatment cancelations at Maryland hospital.


Tangram Furnishes Be Well OC Irvine Behavioral Health Campus

Case study: Through a public-private partnership, Be Well OC’s 22-acre Irvine campus expands Orange County’s continuum of behavioral healthcare.


Suntree Internal Medicine Reports Data Breach

Suntree Internal Medicine has no evidence of misuse, or attempted misuse, of any potentially affected information.


Why Healthcare Facilities Management Is Critical to Patient Safety 

Hospitals and other healthcare facilities rely on much more than doctors and nurses to keep patients safe.


Sanford Health and North Memorial Health Finalize Partnership

An integration process is underway to create a unified organization.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.